FR2341139B1 - - Google Patents

Info

Publication number
FR2341139B1
FR2341139B1 FR7703742A FR7703742A FR2341139B1 FR 2341139 B1 FR2341139 B1 FR 2341139B1 FR 7703742 A FR7703742 A FR 7703742A FR 7703742 A FR7703742 A FR 7703742A FR 2341139 B1 FR2341139 B1 FR 2341139B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7703742A
Other languages
French (fr)
Other versions
FR2341139A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yamasa Shoyu KK
Original Assignee
Yamasa Shoyu KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamasa Shoyu KK filed Critical Yamasa Shoyu KK
Publication of FR2341139A1 publication Critical patent/FR2341139A1/fr
Application granted granted Critical
Publication of FR2341139B1 publication Critical patent/FR2341139B1/fr
Granted legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/804—Radioisotope, e.g. radioimmunoassay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808—Automated or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/826—Additives, e.g. buffers, diluents, preservatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR7703742A 1976-02-12 1977-02-10 Trousse de reactifs pour le dosage de l'adenosine-3', 5'-monophosphate cyclique et du guanosine-3', 5'-monophosphate cyclique Granted FR2341139A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP51014665A JPS5825980B2 (ja) 1976-02-12 1976-02-12 サイクリックヌクレオチドの定量法

Publications (2)

Publication Number Publication Date
FR2341139A1 FR2341139A1 (fr) 1977-09-09
FR2341139B1 true FR2341139B1 (enExample) 1979-10-05

Family

ID=11867499

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7703742A Granted FR2341139A1 (fr) 1976-02-12 1977-02-10 Trousse de reactifs pour le dosage de l'adenosine-3', 5'-monophosphate cyclique et du guanosine-3', 5'-monophosphate cyclique

Country Status (7)

Country Link
US (1) US4115538A (enExample)
JP (1) JPS5825980B2 (enExample)
CA (1) CA1092022A (enExample)
CH (1) CH618015A5 (enExample)
DE (1) DE2705897C3 (enExample)
FR (1) FR2341139A1 (enExample)
GB (1) GB1527465A (enExample)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4378344A (en) * 1979-09-28 1983-03-29 Ventrex Laboratories, Inc. Method and apparatus for performing multiple, simultaneous in vitro diagnostic tests using a solid phase system
US4433061A (en) * 1981-06-01 1984-02-21 American Hospital Supply Corporation Radioimmunoassay for cyclic nucleotides
JPS5811857A (ja) * 1981-07-15 1983-01-22 Yamasa Shoyu Co Ltd アデノシンの定量法
US5118607A (en) * 1989-10-23 1992-06-02 Hawaii Biotechnology Group, Inc. Non-aqueous solvent specific binding protein assays
CA2238283C (en) * 1997-05-30 2002-08-20 Cell Pathways, Inc. Method for identifying compounds for inhibition of neoplastic lesions, pharmaceutical compositions from such compounds and uses of such compounds and compositions for treating neoplastic lesions
US7402400B2 (en) 2001-07-03 2008-07-22 Regents Of The University Of California Mammalian sweet taste receptors
US6686171B2 (en) 1999-05-10 2004-02-03 Tropix, Inc. Competitive chemiluminescent assay for cyclic nucleotide monophosphates
US6794156B2 (en) 1999-05-10 2004-09-21 Applera Corporation Cell growth, induction and lysis in an antibody-coated microplate for use in an ELISA
TW201006846A (en) 2000-03-07 2010-02-16 Senomyx Inc T1R taste receptor and genes encidung same
TW201022287A (en) 2001-01-03 2010-06-16 Senomyx Inc T1R taste receptors and genes encoding same
US7883856B2 (en) 2001-04-05 2011-02-08 Senomyx Inc. Identification of bitter ligands that specifically activate human T2R receptors and related assays for identifying human bitter taste modulators
CA2445197A1 (en) * 2001-04-20 2002-10-31 Mount Sinai School Of Medicine T1r3 a novel taste receptor
US7803982B2 (en) 2001-04-20 2010-09-28 The Mount Sinai School Of Medicine Of New York University T1R3 transgenic animals, cells and related methods
US20070135425A1 (en) * 2001-05-04 2007-06-14 Amgen Inc. Fused heterocyclic compounds
US6809104B2 (en) * 2001-05-04 2004-10-26 Tularik Inc. Fused heterocyclic compounds
WO2003001876A2 (en) 2001-06-26 2003-01-09 Senomyx, Inc. T1r hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds
CA2463553A1 (en) * 2001-10-12 2003-04-17 The Regents Of The University Of California Gastrointestinal chemosensory receptors
EA009421B1 (ru) * 2002-11-06 2007-12-28 Эмджен Инк. Конденсированные гетероциклические соединения
SG145745A1 (en) 2003-08-06 2008-09-29 Senomyx Inc Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof
US20050244810A1 (en) * 2003-09-29 2005-11-03 Egan Josephine M Taste signaling in gastrointestinal cells
EP1937718B1 (en) 2005-10-20 2017-12-06 Senomyx, Inc. Chimeric human sweet-umami and umami-sweet taste receptors
WO2007121604A2 (en) 2006-04-20 2007-11-01 Givaudan Sa Method relating to sweetness enhancement
JP2009533065A (ja) * 2006-04-20 2009-09-17 ジボダン エス エー 味覚物質同定のための機能的方法
US20110097741A1 (en) * 2006-04-20 2011-04-28 Jay Patrick Slack Partial t1r2 nucleic acid sequence, receptor protein and its use in screening assays
EP2010009B1 (en) 2006-04-21 2017-06-14 Senomyx, Inc. Processes for preparing solid flavorant compositions
US8039233B2 (en) * 2007-01-18 2011-10-18 Givaudan S.A. Nucleic acid sequences and their use in methods to identify umami modulatiors
WO2008119195A1 (en) 2007-03-30 2008-10-09 Givaudan Sa Methods to identify modulators
CN101784281B (zh) 2007-08-01 2014-07-02 总医院有限公司 确定g蛋白偶联受体激动剂的方法
HUE025137T2 (en) 2007-08-21 2016-01-28 Senomyx Inc Compositions are bitter taste blocking (blocking) compounds
US9115386B2 (en) 2008-09-26 2015-08-25 Children's Medical Center Corporation Selective oxidation of 5-methylcytosine by TET-family proteins
CN102333536B (zh) 2008-12-29 2014-08-13 特维那公司 β-抑制蛋白效应器和组合物以及其应用方法
CN102481276A (zh) 2009-04-20 2012-05-30 埃尔舍利克斯治疗公司 基于化学感受受体配体的治疗法
US9901551B2 (en) 2009-04-20 2018-02-27 Ambra Bioscience Llc Chemosensory receptor ligand-based therapies
US8828953B2 (en) * 2009-04-20 2014-09-09 NaZura BioHealth, Inc. Chemosensory receptor ligand-based therapies
EP2567231A1 (en) 2010-05-07 2013-03-13 Givaudan SA Methods to identify modulators of tas2r4s receptors
US20130115624A1 (en) 2010-05-07 2013-05-09 Givaudan S.A. Methods To Identify Modulators
CN104220875A (zh) 2010-10-19 2014-12-17 埃尔舍利克斯治疗公司 基于化学感应受体配体的治疗
SG191855A1 (en) 2011-01-07 2013-08-30 Elcelyx Therapeutics Inc Chemosensory receptor ligand-based therapies
WO2012129495A1 (en) 2011-03-23 2012-09-27 Trevena, Inc. Opioid receptor ligands and methods of using and making same
US20130040317A1 (en) 2011-08-08 2013-02-14 The University Of North Carolina At Chapel Hill Cell lines comprising endogenous taste receptors and their uses
EP2742350B1 (en) 2011-08-08 2019-10-30 The Coca-Cola Company Cell lines comprising endogenous taste receptors and their uses
CA2862933A1 (en) 2012-01-31 2013-08-08 Trevena, Inc. .beta.-arrestin effectors and compositions and methods of use thereof
WO2013158928A2 (en) 2012-04-18 2013-10-24 Elcelyx Therapeutics, Inc. Chemosensory receptor ligand-based therapies
NZ710444A (en) 2013-02-11 2020-08-28 Univ California Compositions and methods for treating neurodegenerative diseases and cardiomyopathy
EP2983507B1 (en) 2013-03-15 2020-04-22 Applied Food Biotechnology, Inc. Feline bitter taste receptors and methods
EP3102223A4 (en) 2014-02-07 2017-11-29 Trevena, Inc. Crystalline and amorphous forms of a beta-arrestin effector
WO2015123365A1 (en) 2014-02-11 2015-08-20 Mitokinin Llc Compositions and methods using the same for treatment of neurodegenerative and mitochondrial disease
CA2948858A1 (en) 2014-05-19 2015-11-26 Trevena, Inc. Synthesis of beta-arrestin effectors
PL3344248T3 (pl) 2015-09-02 2022-07-18 Trevena, Inc. Zawierające sześcioczłonowy aza-heterocykl związki modulujące receptor opioidowy delta oraz sposoby ich wykorzystywania i wytwarzania
CA3007020A1 (en) 2015-12-14 2017-06-22 Trevena, Inc. Methods of treating hyperalgesia
US20190178889A1 (en) * 2016-09-05 2019-06-13 BellBrook Labs High-throughput screening assay
KR102662065B1 (ko) 2017-02-17 2024-05-07 트레베나, 인코포레이티드. 7-원 아자-헤테로고리 함유 델타-오피오이드 수용체 조절 화합물, 및 그의 사용 및 제조 방법
KR20190129867A (ko) 2017-02-17 2019-11-20 트레베나, 인코포레이티드. 5-원 아자-헤테로고리 함유 델타-오피오이드 수용체 조절 화합물, 및 그의 사용 및 제조 방법
CA3067695A1 (en) 2017-06-21 2018-12-27 Mitokinin, Inc. Compositions and methods using the same for treatment of neurodegenerative and mitochondrial disease
CN112858504A (zh) * 2021-01-08 2021-05-28 苏州国辰生物科技股份有限公司 一种液质联用测定生物体液样品中cGMP浓度的检测方法
WO2023154597A1 (en) 2022-02-11 2023-08-17 Firmenich Incorporated Cells expressing umami taste receptors and uses thereof

Also Published As

Publication number Publication date
JPS5825980B2 (ja) 1983-05-31
FR2341139A1 (fr) 1977-09-09
US4115538A (en) 1978-09-19
GB1527465A (en) 1978-10-04
CA1092022A (en) 1980-12-23
DE2705897B2 (de) 1979-06-21
CH618015A5 (enExample) 1980-06-30
DE2705897C3 (de) 1980-02-28
JPS52117418A (en) 1977-10-01
DE2705897A1 (de) 1977-08-18

Similar Documents

Publication Publication Date Title
FR2341139B1 (enExample)
CS175529B1 (enExample)
CS177748B1 (enExample)
CS177781B1 (enExample)
DD125409A1 (enExample)
BG23140A1 (enExample)
BG23385A1 (enExample)
BG23394A1 (enExample)
CH412376A4 (enExample)
CH594553A5 (enExample)
CH595573A5 (enExample)
CH595941A5 (enExample)
CH596023A5 (enExample)
CH596513A5 (enExample)
CH596922A5 (enExample)
CH597017A5 (enExample)
CH597434A5 (enExample)
CH598462A5 (enExample)
CH598844A5 (enExample)
CH599395A5 (enExample)
CH600862A5 (enExample)
CH603330A5 (enExample)
CH603359A5 (enExample)
CH603383A5 (enExample)
CH604351A5 (enExample)

Legal Events

Date Code Title Description
ST Notification of lapse